REFERENCES
- Ahmed S. A., Penhale W. J., Talal N. Sex hormones, immune responses and autoimmune diseases. American Journal of Pathology 1985; 121: 531–551
- Ahmed S. A., Talal N. Importance of sex hormones in lupus. Dubois' Lupus Erythematosus, D. J. Wallace, B. H. Hahn. Lea Febiger, Philadelphia 1993; 148–156
- Ahmed S. A., Hissong B. D., Verthelye D., Donner K., Becker K., Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: Possible role of estrogenic compounds. Environ. Health Perspect 1999; 107(suppl. 5)681–686, [PUBMED], [INFOTRIEVE], [CSA]
- Beeson P. B. Age and sex associations of 40 autoimmune diseases. Am. J. Med. 1994; 96: 457–462, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Calabrese E. J., Baldwin L. A. Hormesis at the National Toxicology Program (NTP): Evidence of hormetic dose responses in the NTP dose-range studies. Nonlinearity Biol. Toxicol. Med. 2003; 1: 455–467, [CROSSREF]
- Calemine J. B., Gogal R. M., Jr, Lengi A., Sponenberg P., Ahmed S. A. Immunomodulation by diethylstilbestrol is dose and gender related: Effects on thymocyte apoptosis and mitogen-induced proliferation. Toxicology 2002; 178: 101–118, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Do Y., Ryu S., Nagarkatti M., Nagarkatti P. S. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. Toxicol. Sci. 2002; 70: 63–72, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Eaton D. L., Klaassen C. D. Principles of toxicology. Casarett and Doull's toxicology: The basic science of poisons, 6th ed., C. D. Klaassen. McGraw-Hill, New York 2001; 11–34
- Gould K. A., Shull J. D., Gorski J. DES action in the thymus: Inhibition of cell proliferation and genetic variation. Mol. Cell. Endocrinol. 2000; 170: 31–39, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Haukaas S. A., Kalland T. Effects of diethylstilbestrol and estramustine phosphate (Estracyt) on lymphoid cell populations and mitogen responsiveness in male mice. J. Urol. 1982; 128: 862–868, [PUBMED], [INFOTRIEVE]
- Holladay S. D., Blaylock B. L., Comment C. E., Heindel J. J., Fox W. M., Korach K. S., Luster M. I. Selective prothymocyte targeting by prenatal diethylstilbestrol exposure. Cell. Immunol. 1993; 152: 131–142, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kalland T. Environmental factors in human growth development, V. Hunt, M. K. Smith, D. Worth. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 1982; 217
- Karpuzoglu-Sahin E., Zhi-Jun Y., Lengi A., Sriranganathan N., Ahmed S. A. Effects of long-term estrogen treatment on IFN-γ, IL-2 and IL-4 gene expression and protein sysntesis in spleen and thymus of normal C57Bl/6 mice. Cytokine 2001a; 14: 208–217, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Karpuzoglu-Sahin E., Hissong B. D., Ahmed S. A. Interferon-γ levels are upregulated by 17-β-estradiol and diethylstilbestrol. J. Reprod. Immunol. 2001b; 52: 113–127, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lai Z. W., Fiore N. C., Hahn P. J., Gasiewicz T. Z., Silverstone A. E. Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol. Appl. Pharmacol. 2000; 168: 15–24, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Landsman T., Leitner G., Robinzon T. B., Helle E. D. Effect of gonadal steroids on proliferative responses and subset alterations in cultured chicken lymphocytes. Poul. Sci. 2001; 80: 1329–1338, [CSA]
- Luster M. I., Boorman G. A., Dean J. H., Lawson L. D., Wilson R., Haseman J. K. Biological relevance of immunosuppression, J. H. Dean, M. L. Padarathsingh. Van Nostrand, New York 1981; 153–157
- Luster M. I., Portier C., Pair D. G., White K.L., Jr., Gennings C., Munson A. E., Rosenthal G. J. Risk assessment in immunotoxicology I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 1992; 18: 200–210, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Olsen N. J., Kovacs W. J. Gonadal steroids and immunity. Endoc. Rev. 1996; 17: 369–384, [CROSSREF], [CSA]
- Silverstone A. E., Frazier D. E., Jr., Fiore N. C., Soults J. A., Gasiewicz T. A. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlordibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol. 1994; 126: 248–259, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yao G., Hou Y. Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway. Int. Immunopharmacol. 2004; 4: 213–221, [PUBMED], [INFOTRIEVE], [CROSSREF]